oweng personal page - To The Moon

oweng

oweng

No personal profile

345Follow

4Followers

0Topic

0Badge

2021-06-09

Bitcoin is time to run?

Sorry, the original content has been removed

2023-03-31

$凯德商用新加坡信托(C38U.SI)$

2023-03-30

[微笑]

@格隆汇:華領醫藥業績解讀：商業化成績顯著，亮眼業績驗證價值成長

2022-12-30

[财迷]

Sorry, the original content has been removed

2022-12-02

$纳指100ETF(QQQ)$

2022-12-02

[流泪]

Sorry, the original content has been removed

2022-09-05

[微笑]

Sorry, the original content has been removed

2021-02-26

！？

Sorry, the original content has been removed

2021-02-22

W

Sorry, the original content has been removed

2021-02-11

。。。。

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3575152427021429","uuid":"3575152427021429","gmtCreate":1612066505475,"gmtModify":1612426383219,"name":"oweng","pinyin":"oweng","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":345,"tweetSize":125,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.61%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.84%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9941646166,"gmtCreate":1680231234256,"gmtModify":1680231236770,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C38U.SI\">$凯德商用新加坡信托(C38U.SI)$&nbsp;</a><v-v data-views=\"1\"></v-v>","listText":"<a href=\"https://ttm.financial/S/C38U.SI\">$凯德商用新加坡信托(C38U.SI)$&nbsp;</a><v-v data-views=\"1\"></v-v>","text":"$凯德商用新加坡信托(C38U.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9941646166","isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9941844730,"gmtCreate":1680159661720,"gmtModify":1680159665488,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"[微笑]","listText":"[微笑]","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9941844730","repostId":"659558323","repostType":1,"repost":{"id":659558323,"gmtCreate":1680158446564,"gmtModify":1680159403698,"author":{"id":"39105730803552","authorId":"39105730803552","name":"格隆汇","avatar":"https://static.tigerbbs.com/8774dfe20eceb38c9645128bb6e60684","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"39105730803552","authorIdStr":"39105730803552"},"themes":[],"title":"華領醫藥業績解讀：商業化成績顯著，亮眼業績驗證價值成長","htmlText":"過去一年，隨着新冠疫情趨於常態化，衆多醫藥公司在業績兌現估值到頂後，進入普跌階段。受此影響，整個醫藥板塊持續低迷，其中，港股生物醫藥板塊跌幅達到了37%。即便如此，仍然不乏亮眼表現者，其中就包括近期交出財報的華領醫藥（2552.HK）。從過去一年資本市場的情況來看，2022年華領醫藥儘管收跌，但跌幅僅爲1.32%，大幅跑贏板塊乃至整個大市行情。&nbsp; <a href=\"https://laohu8.com/S/02552\">$華領醫藥-B(02552)$</a> 分析原因來看，一個很重要的因素便在於其重磅產品的商業化爲資本市場帶來了良好預期，基於此公司股價一度接連幾輪實現大漲，但隨後也遭遇下挫，一定程度也反映了市場存在分歧。隨着公司年度財報的公佈，公司進一步披露商業化成績單，這也爲投資者帶來了一個新的窗口期審慎公司長期價值。&nbsp;1、管線研發與商業化齊頭並進從財報來看，公司業績取得重大突破。&nbsp;在10月底其重磅在研產品正式商業化上市後，華堂寧®共售出約5.3萬盒，實現銷售收入約1760萬元。而在此前公司披露的公告中，截至2023年1月底，華堂寧®售出約14.8萬盒，淨銷售收入約爲4900萬元。&nbsp;在短短兩個月時間內，不論是銷量還是銷售收入，均展現出了強勁的增長態勢，而此後的新批次藥品恢復供應後，更是在1個月時間內銷售了近10萬盒，這也充分表明了公司該款重磅藥物受到市場的認可。&nbsp;一般而言，在創新藥領域，藥品銷售對於商業化能力往往有着相當高的要求，而此次華領醫藥華寧堂的銷售數據充分展現了其強大的商業化實力。&nbsp;究其原因來看，首先在於該款藥物滿足了市場的核心需要。&nbsp;通常創新藥進入市場初期往往需要一段市場接受期，而華寧堂卻能夠快速實現放量，這也凸顯了該藥物在醫生、患者中間的認可度。&nbsp;作爲全球第一款獲批上市的葡萄糖激酶","listText":"過去一年，隨着新冠疫情趨於常態化，衆多醫藥公司在業績兌現估值到頂後，進入普跌階段。受此影響，整個醫藥板塊持續低迷，其中，港股生物醫藥板塊跌幅達到了37%。即便如此，仍然不乏亮眼表現者，其中就包括近期交出財報的華領醫藥（2552.HK）。從過去一年資本市場的情況來看，2022年華領醫藥儘管收跌，但跌幅僅爲1.32%，大幅跑贏板塊乃至整個大市行情。&nbsp; <a href=\"https://laohu8.com/S/02552\">$華領醫藥-B(02552)$</a> 分析原因來看，一個很重要的因素便在於其重磅產品的商業化爲資本市場帶來了良好預期，基於此公司股價一度接連幾輪實現大漲，但隨後也遭遇下挫，一定程度也反映了市場存在分歧。隨着公司年度財報的公佈，公司進一步披露商業化成績單，這也爲投資者帶來了一個新的窗口期審慎公司長期價值。&nbsp;1、管線研發與商業化齊頭並進從財報來看，公司業績取得重大突破。&nbsp;在10月底其重磅在研產品正式商業化上市後，華堂寧®共售出約5.3萬盒，實現銷售收入約1760萬元。而在此前公司披露的公告中，截至2023年1月底，華堂寧®售出約14.8萬盒，淨銷售收入約爲4900萬元。&nbsp;在短短兩個月時間內，不論是銷量還是銷售收入，均展現出了強勁的增長態勢，而此後的新批次藥品恢復供應後，更是在1個月時間內銷售了近10萬盒，這也充分表明了公司該款重磅藥物受到市場的認可。&nbsp;一般而言，在創新藥領域，藥品銷售對於商業化能力往往有着相當高的要求，而此次華領醫藥華寧堂的銷售數據充分展現了其強大的商業化實力。&nbsp;究其原因來看，首先在於該款藥物滿足了市場的核心需要。&nbsp;通常創新藥進入市場初期往往需要一段市場接受期，而華寧堂卻能夠快速實現放量，這也凸顯了該藥物在醫生、患者中間的認可度。&nbsp;作爲全球第一款獲批上市的葡萄糖激酶","text":"過去一年，隨着新冠疫情趨於常態化，衆多醫藥公司在業績兌現估值到頂後，進入普跌階段。受此影響，整個醫藥板塊持續低迷，其中，港股生物醫藥板塊跌幅達到了37%。即便如此，仍然不乏亮眼表現者，其中就包括近期交出財報的華領醫藥（2552.HK）。從過去一年資本市場的情況來看，2022年華領醫藥儘管收跌，但跌幅僅爲1.32%，大幅跑贏板塊乃至整個大市行情。 $華領醫藥-B(02552)$ 分析原因來看，一個很重要的因素便在於其重磅產品的商業化爲資本市場帶來了良好預期，基於此公司股價一度接連幾輪實現大漲，但隨後也遭遇下挫，一定程度也反映了市場存在分歧。隨着公司年度財報的公佈，公司進一步披露商業化成績單，這也爲投資者帶來了一個新的窗口期審慎公司長期價值。 1、管線研發與商業化齊頭並進從財報來看，公司業績取得重大突破。 在10月底其重磅在研產品正式商業化上市後，華堂寧®共售出約5.3萬盒，實現銷售收入約1760萬元。而在此前公司披露的公告中，截至2023年1月底，華堂寧®售出約14.8萬盒，淨銷售收入約爲4900萬元。 在短短兩個月時間內，不論是銷量還是銷售收入，均展現出了強勁的增長態勢，而此後的新批次藥品恢復供應後，更是在1個月時間內銷售了近10萬盒，這也充分表明了公司該款重磅藥物受到市場的認可。 一般而言，在創新藥領域，藥品銷售對於商業化能力往往有着相當高的要求，而此次華領醫藥華寧堂的銷售數據充分展現了其強大的商業化實力。 究其原因來看，首先在於該款藥物滿足了市場的核心需要。 通常創新藥進入市場初期往往需要一段市場接受期，而華寧堂卻能夠快速實現放量，這也凸顯了該藥物在醫生、患者中間的認可度。 作爲全球第一款獲批上市的葡萄糖激酶","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/659558323","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9927973584,"gmtCreate":1672382663549,"gmtModify":1676538682532,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9927973584","repostId":"1144664449","repostType":4,"isVote":1,"tweetType":1,"viewCount":497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9965638255,"gmtCreate":1669942773677,"gmtModify":1676538274333,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/QQQ\">$纳指100ETF(QQQ)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/QQQ\">$纳指100ETF(QQQ)$ &nbsp;</a>","text":"$纳指100ETF(QQQ)$","images":[{"img":"https://community-static.tradeup.com/news/b57ec0ab88b4dd6568b9f993951f5e62","width":"1080","height":"2072"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9965638255","isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9965631963,"gmtCreate":1669942651152,"gmtModify":1676538274294,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"[流泪]&nbsp;","listText":"[流泪]&nbsp;","text":"[流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9965631963","repostId":"1176648446","repostType":4,"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9931010300,"gmtCreate":1662357612001,"gmtModify":1676537044743,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9931010300","repostId":"1113274619","repostType":4,"isVote":1,"tweetType":1,"viewCount":424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180228429,"gmtCreate":1623207363661,"gmtModify":1704198370745,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"Bitcoin is time to run?","listText":"Bitcoin is time to run?","text":"Bitcoin is time to run?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180228429","repostId":"2142293923","repostType":4,"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":368385655,"gmtCreate":1614292043677,"gmtModify":1704770192892,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"！？","listText":"！？","text":"！？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/368385655","repostId":"1110328938","repostType":4,"isVote":1,"tweetType":1,"viewCount":649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360475532,"gmtCreate":1613972284326,"gmtModify":1704886310956,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"W","listText":"W","text":"W","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/360475532","repostId":"2113082690","repostType":4,"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":388015414,"gmtCreate":1613001617438,"gmtModify":1704877205735,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"。。。。","listText":"。。。。","text":"。。。。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/388015414","repostId":"2110801775","repostType":4,"isVote":1,"tweetType":1,"viewCount":486,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":180228429,"gmtCreate":1623207363661,"gmtModify":1704198370745,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"Bitcoin is time to run?","listText":"Bitcoin is time to run?","text":"Bitcoin is time to run?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180228429","repostId":"2142293923","repostType":4,"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9941646166,"gmtCreate":1680231234256,"gmtModify":1680231236770,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C38U.SI\">$凯德商用新加坡信托(C38U.SI)$&nbsp;</a><v-v data-views=\"1\"></v-v>","listText":"<a href=\"https://ttm.financial/S/C38U.SI\">$凯德商用新加坡信托(C38U.SI)$&nbsp;</a><v-v data-views=\"1\"></v-v>","text":"$凯德商用新加坡信托(C38U.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9941646166","isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9941844730,"gmtCreate":1680159661720,"gmtModify":1680159665488,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"[微笑]","listText":"[微笑]","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9941844730","repostId":"659558323","repostType":1,"repost":{"id":659558323,"gmtCreate":1680158446564,"gmtModify":1680159403698,"author":{"id":"39105730803552","authorId":"39105730803552","name":"格隆汇","avatar":"https://static.tigerbbs.com/8774dfe20eceb38c9645128bb6e60684","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"39105730803552","authorIdStr":"39105730803552"},"themes":[],"title":"華領醫藥業績解讀：商業化成績顯著，亮眼業績驗證價值成長","htmlText":"過去一年，隨着新冠疫情趨於常態化，衆多醫藥公司在業績兌現估值到頂後，進入普跌階段。受此影響，整個醫藥板塊持續低迷，其中，港股生物醫藥板塊跌幅達到了37%。即便如此，仍然不乏亮眼表現者，其中就包括近期交出財報的華領醫藥（2552.HK）。從過去一年資本市場的情況來看，2022年華領醫藥儘管收跌，但跌幅僅爲1.32%，大幅跑贏板塊乃至整個大市行情。&nbsp; <a href=\"https://laohu8.com/S/02552\">$華領醫藥-B(02552)$</a> 分析原因來看，一個很重要的因素便在於其重磅產品的商業化爲資本市場帶來了良好預期，基於此公司股價一度接連幾輪實現大漲，但隨後也遭遇下挫，一定程度也反映了市場存在分歧。隨着公司年度財報的公佈，公司進一步披露商業化成績單，這也爲投資者帶來了一個新的窗口期審慎公司長期價值。&nbsp;1、管線研發與商業化齊頭並進從財報來看，公司業績取得重大突破。&nbsp;在10月底其重磅在研產品正式商業化上市後，華堂寧®共售出約5.3萬盒，實現銷售收入約1760萬元。而在此前公司披露的公告中，截至2023年1月底，華堂寧®售出約14.8萬盒，淨銷售收入約爲4900萬元。&nbsp;在短短兩個月時間內，不論是銷量還是銷售收入，均展現出了強勁的增長態勢，而此後的新批次藥品恢復供應後，更是在1個月時間內銷售了近10萬盒，這也充分表明了公司該款重磅藥物受到市場的認可。&nbsp;一般而言，在創新藥領域，藥品銷售對於商業化能力往往有着相當高的要求，而此次華領醫藥華寧堂的銷售數據充分展現了其強大的商業化實力。&nbsp;究其原因來看，首先在於該款藥物滿足了市場的核心需要。&nbsp;通常創新藥進入市場初期往往需要一段市場接受期，而華寧堂卻能夠快速實現放量，這也凸顯了該藥物在醫生、患者中間的認可度。&nbsp;作爲全球第一款獲批上市的葡萄糖激酶","listText":"過去一年，隨着新冠疫情趨於常態化，衆多醫藥公司在業績兌現估值到頂後，進入普跌階段。受此影響，整個醫藥板塊持續低迷，其中，港股生物醫藥板塊跌幅達到了37%。即便如此，仍然不乏亮眼表現者，其中就包括近期交出財報的華領醫藥（2552.HK）。從過去一年資本市場的情況來看，2022年華領醫藥儘管收跌，但跌幅僅爲1.32%，大幅跑贏板塊乃至整個大市行情。&nbsp; <a href=\"https://laohu8.com/S/02552\">$華領醫藥-B(02552)$</a> 分析原因來看，一個很重要的因素便在於其重磅產品的商業化爲資本市場帶來了良好預期，基於此公司股價一度接連幾輪實現大漲，但隨後也遭遇下挫，一定程度也反映了市場存在分歧。隨着公司年度財報的公佈，公司進一步披露商業化成績單，這也爲投資者帶來了一個新的窗口期審慎公司長期價值。&nbsp;1、管線研發與商業化齊頭並進從財報來看，公司業績取得重大突破。&nbsp;在10月底其重磅在研產品正式商業化上市後，華堂寧®共售出約5.3萬盒，實現銷售收入約1760萬元。而在此前公司披露的公告中，截至2023年1月底，華堂寧®售出約14.8萬盒，淨銷售收入約爲4900萬元。&nbsp;在短短兩個月時間內，不論是銷量還是銷售收入，均展現出了強勁的增長態勢，而此後的新批次藥品恢復供應後，更是在1個月時間內銷售了近10萬盒，這也充分表明了公司該款重磅藥物受到市場的認可。&nbsp;一般而言，在創新藥領域，藥品銷售對於商業化能力往往有着相當高的要求，而此次華領醫藥華寧堂的銷售數據充分展現了其強大的商業化實力。&nbsp;究其原因來看，首先在於該款藥物滿足了市場的核心需要。&nbsp;通常創新藥進入市場初期往往需要一段市場接受期，而華寧堂卻能夠快速實現放量，這也凸顯了該藥物在醫生、患者中間的認可度。&nbsp;作爲全球第一款獲批上市的葡萄糖激酶","text":"過去一年，隨着新冠疫情趨於常態化，衆多醫藥公司在業績兌現估值到頂後，進入普跌階段。受此影響，整個醫藥板塊持續低迷，其中，港股生物醫藥板塊跌幅達到了37%。即便如此，仍然不乏亮眼表現者，其中就包括近期交出財報的華領醫藥（2552.HK）。從過去一年資本市場的情況來看，2022年華領醫藥儘管收跌，但跌幅僅爲1.32%，大幅跑贏板塊乃至整個大市行情。 $華領醫藥-B(02552)$ 分析原因來看，一個很重要的因素便在於其重磅產品的商業化爲資本市場帶來了良好預期，基於此公司股價一度接連幾輪實現大漲，但隨後也遭遇下挫，一定程度也反映了市場存在分歧。隨着公司年度財報的公佈，公司進一步披露商業化成績單，這也爲投資者帶來了一個新的窗口期審慎公司長期價值。 1、管線研發與商業化齊頭並進從財報來看，公司業績取得重大突破。 在10月底其重磅在研產品正式商業化上市後，華堂寧®共售出約5.3萬盒，實現銷售收入約1760萬元。而在此前公司披露的公告中，截至2023年1月底，華堂寧®售出約14.8萬盒，淨銷售收入約爲4900萬元。 在短短兩個月時間內，不論是銷量還是銷售收入，均展現出了強勁的增長態勢，而此後的新批次藥品恢復供應後，更是在1個月時間內銷售了近10萬盒，這也充分表明了公司該款重磅藥物受到市場的認可。 一般而言，在創新藥領域，藥品銷售對於商業化能力往往有着相當高的要求，而此次華領醫藥華寧堂的銷售數據充分展現了其強大的商業化實力。 究其原因來看，首先在於該款藥物滿足了市場的核心需要。 通常創新藥進入市場初期往往需要一段市場接受期，而華寧堂卻能夠快速實現放量，這也凸顯了該藥物在醫生、患者中間的認可度。 作爲全球第一款獲批上市的葡萄糖激酶","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/659558323","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9927973584,"gmtCreate":1672382663549,"gmtModify":1676538682532,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9927973584","repostId":"1144664449","repostType":4,"isVote":1,"tweetType":1,"viewCount":497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9965638255,"gmtCreate":1669942773677,"gmtModify":1676538274333,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/QQQ\">$纳指100ETF(QQQ)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/QQQ\">$纳指100ETF(QQQ)$ &nbsp;</a>","text":"$纳指100ETF(QQQ)$","images":[{"img":"https://community-static.tradeup.com/news/b57ec0ab88b4dd6568b9f993951f5e62","width":"1080","height":"2072"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9965638255","isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9965631963,"gmtCreate":1669942651152,"gmtModify":1676538274294,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"[流泪]&nbsp;","listText":"[流泪]&nbsp;","text":"[流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9965631963","repostId":"1176648446","repostType":4,"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9931010300,"gmtCreate":1662357612001,"gmtModify":1676537044743,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9931010300","repostId":"1113274619","repostType":4,"isVote":1,"tweetType":1,"viewCount":424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":368385655,"gmtCreate":1614292043677,"gmtModify":1704770192892,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"！？","listText":"！？","text":"！？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/368385655","repostId":"1110328938","repostType":4,"isVote":1,"tweetType":1,"viewCount":649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360475532,"gmtCreate":1613972284326,"gmtModify":1704886310956,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"W","listText":"W","text":"W","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/360475532","repostId":"2113082690","repostType":4,"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":388015414,"gmtCreate":1613001617438,"gmtModify":1704877205735,"author":{"id":"3575152427021429","authorId":"3575152427021429","name":"oweng","avatar":"https://static.tigerbbs.com/78ba73c35834e0f9da0d306a62c079e3","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575152427021429","authorIdStr":"3575152427021429"},"themes":[],"htmlText":"。。。。","listText":"。。。。","text":"。。。。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/388015414","repostId":"2110801775","repostType":4,"isVote":1,"tweetType":1,"viewCount":486,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}